Social Media Ideas for Jtekf

JTEKT Corporation 2027 Q1 - Results - Earnings Call Presentation

Teleflex: Portfolio Surgery Creates A Better Medtech Compounder

Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal

Taiho Pharmaceutical and Cullinan Therapeutics have celebrated a second phase 3 victory for their small-molecule EGFR inhibitor, teeing up the partners to challenge Johnson & J...

Toyoda Gosei Co., Ltd. 2027 Q1 - Results - Earnings Call Presentation

株式会社FRONTEOとの資本提携の実施及び難治性がん領域におけるマイクロRNA核酸医薬の標的分子候補探索・作用機序解明に向けたPo...

株式会社FRONTEOとの資本提携の実施及び難治性がん領域におけるマイクロRNA核酸医薬の標的分子候補探索・作用機序解明に向けたPoCの開始について

Alpha Teknova, Inc. 2026 Q2 - Results - Earnings Call Presentation

Alpha Teknova, Inc. (TKNO) Q2 2026 Earnings Call Transcript

JTEKT completes sale of European automotive business

The early completion signals JTEKT is prioritising speed as it reshapes its global supplier footprint under its latest plan The post JTEKT completes sale of European automotive bus...

Takeda gains approval of rusfertide for polycythemia vera

BioXcel files for Chapter 11, will sell assets to Teva

Nabtesco Corporation 2026 Q2 - Results - Earnings Call Presentation

10 biotechs in Japan to watch in 2026 

While Japan historically lacked foreign investment, the field is becoming more dynamic. Discover ten essential biotech companies in Japan. The post 10 biotechs in Japan to watch in...

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein in certain thymus-related indications in the Americas a...

ATEC Reports Second Quarter Financial Results

CARLSBAD, Calif., August 4, 2026 -(BUSINESS WIRE)- Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions…

<![CDATA[Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience]]>

PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market

PTC Therapeutics has struck a deal to buy Sangamo Therapeutics’ Fabry disease program for $111 million upfront, outbidding Astellas and TerSera Therapeutics for the near-approval g...

Kyocera Medical Technologies, Inc. Announces Launch of Tesera®-K XL System, Advancing 3D-printed Lateral Spine Surgery S...

REDLANDS, CA — July 7, 2026 — Kyocera Medical Technologies, Inc. is proud to announce the launch of the Tesera®-K XL Lateral Interbody Fusion System, enabling minimally invasive sp...

ATEC Announces Participation in Upcoming Investor Conferences

CARLSBAD, Calif., July 27, 2026 -(BUSINESS WIRE)- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated…

Tata Technologies Q1 Results: Profit rises 6% to Rs 180 crore

Tata Technologies has achieved an impressive 6.2 percent increase in profits for the June quarter, alongside a notable rise in consolidated revenues year-over-year. A strategic par...

Tenpoint

Tenpoint Anonymous (not verified) Sun, 07/12/2026 - 12:13 field_thread_url https://cafepharma.com/boards/threads/tenpoint.711562/ board...

Tepezza Expansion feedback

Tepezza Expansion feedback Anonymous (not verified) Wed, 07/22/2026 - 15:21 field_thread_url https://cafepharma.com/boards/threads/tepezza-expansion-feedba...

Javelin Joint Venture and Tata Advanced Systems Signs Agreement for Missile Co-Production in India

Tata Advanced Systems Limited and the Javelin Joint Venture (JJV), a partnership between Raytheon, an RTX business, and Lockheed Martin (NYSE: LMT), have entered into a memorandum...

Toyota Motor: Growth, High Profitability, 9.5x P/E